✉news TechnologyAI first seen 5 d ago, last 5 d ago, peak #35
AI drug discovery firm Iambic raises $150M in IPO
Original: Iambic, an AI drug discovery specialist, banks $150M in an IPO
Iambic Therapeutics, a company using artificial intelligence to speed up drug discovery, has raised $150 million in an initial public offering. The listing gives the AI biotech specialist fresh capital to advance its pipeline of machine learning-designed drug candidates and marks another test of investor appetite for AI-powered pharmaceutical development.
Why now: The IPO is fresh news and signals renewed investor confidence in AI-driven biotech companies going public.
Evidence
- Iambic, an AI drug discovery specialist, banks $150M in an IPO · BioPharma Dive
API: https://socialmediatrends-api.osmike.com/v1/trends/2305202